These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9664369)

  • 1. Production of bispecific and trispecific F(ab)2 and F(ab)3 antibody derivatives.
    French RR
    Methods Mol Biol; 1998; 80():121-34. PubMed ID: 9664369
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of bifunctional antibodies for immunoassays.
    DeSilva BS; Wilson GS
    Methods; 2000 Sep; 22(1):33-43. PubMed ID: 11020315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells.
    Somasundaram C; Sundarapandiyan K; Keler T; Deo YM; Graziano RF
    Hum Antibodies; 1999; 9(1):47-54. PubMed ID: 10331185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.
    Cheung GL; Thomas TM; Rylatt DB
    Protein Expr Purif; 2003 Nov; 32(1):135-40. PubMed ID: 14680950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor therapy with bispecific antibody: the targeting and triggering steps can be separated employing a CD2-based strategy.
    Wild MK; Strittmatter W; Matzku S; Schraven B; Meuer SC
    J Immunol; 1999 Aug; 163(4):2064-72. PubMed ID: 10438945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid phase synthesis of bifunctional antibodies.
    DeSilva BS; Wilson GS
    J Immunol Methods; 1995 Dec; 188(1):9-19. PubMed ID: 8551042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of thiophilic adsorption chromatography for the one-step purification of a bacterially produced antibody F(ab) fragment without the need for an affinity tag.
    Fiedler M; Skerra A
    Protein Expr Purif; 1999 Dec; 17(3):421-7. PubMed ID: 10600461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a filamentous phage pVIII fusion protein system suitable for efficient production, screening, and mutagenesis of F(ab) antibody fragments.
    Huse WD; Stinchcombe TJ; Glaser SM; Starr L; MacLean M; Hellström KE; Hellström I; Yelton DE
    J Immunol; 1992 Dec; 149(12):3914-20. PubMed ID: 1460282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragmentation of immunoglobulin G.
    Andrew SM; Titus JA
    Curr Protoc Cell Biol; 2003 Feb; Chapter 16():Unit 16.4. PubMed ID: 18228421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of bispecific antibodies.
    Segal DM; Bast BJEG
    Curr Protoc Immunol; 2001 May; Chapter 2():2.13.1-2.13.16. PubMed ID: 18432765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward the production of bispecific antibody fragments for clinical applications.
    Carter P; Ridgway J; Zhu Z
    J Hematother; 1995 Oct; 4(5):463-70. PubMed ID: 8581386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unfolding/denaturation of immunogammaglobulin of isotype 2b and its F(ab) and F(c) fragments.
    Vermeer AW; Norde W; van Amerongen A
    Biophys J; 2000 Oct; 79(4):2150-4. PubMed ID: 11023918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of F(ab')2 fragments from mouse IgG of various subclasses.
    Lamoyi E
    Methods Enzymol; 1986; 121():652-63. PubMed ID: 3088385
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification of reduced and alkylated antibody subunits.
    Sun M; Paul S
    Methods Mol Biol; 1995; 51():111-22. PubMed ID: 7581690
    [No Abstract]   [Full Text] [Related]  

  • 16. Mouse IgG2b monoclonal antibody fragmentation. Preparation and purification of Fab, Fc and Fab/c fragments.
    Demignot S; Garnett MC; Baldwin RW
    J Immunol Methods; 1989 Jul; 121(2):209-17. PubMed ID: 2503561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bispecific antibodies: molecules that enable novel therapeutic strategies.
    Fischer N; Léger O
    Pathobiology; 2007; 74(1):3-14. PubMed ID: 17496428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical production of bispecific antibodies.
    Graziano RF; Guptill P
    Methods Mol Biol; 2004; 283():71-85. PubMed ID: 15197303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
    Venturi M; Seifert C; Hunte C
    J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-step purification of pepsin-derived monoclonal antibody fragments from crude murine ascitic fluids by ceramic hydroxyapatite high-performance liquid chromatography.
    Moro A; Yoshitake T; Ogawa T; Ichimura T
    J Biochem; 2008 Dec; 144(6):733-9. PubMed ID: 18835826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.